Published 16 days ago • loading... • Updated 16 days ago

#Dexcoms State of Type 2 Report Reveals HCP Preference for Tech Solutions Amid Albertas Expanded CGM Acces...

Summary by csimarket.com

The Future of Type 2 Diabetes Management: Embracing Technology Over Medication In a groundbreaking reveal during the Advanced Technologies and Treatments for Diabetes (ATTD) 2025 conference held in Edinburgh, Scotland, DexCom, Inc. (NASDAQ: DXCM) has launched its inaugural multi-region report titled the Dexcom State of Type 2 Report: Access and Attitudes Across Europe and the Middle East. This extensive study surveyed over 2,500 individuals, inc…

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All

Left

Center

Right

Drug Delivery Business

Dexcom survey says providers want tech over medication for type 2

The G7 CGM. [Image courtesy of Dexcom]Dexcom (Nadsaq:DXCM) announced today that it launched a new multi-region report evaluating type 2 diabetes treatments. The “Dexcom State of Type 2 Report: Access and Attitudes Across Europe and the Middle East” surveyed 2,500 people. It featured individuals with type 2 diabetes and healthcare professionals across Germany, Italy, the Netherlands, Saudi Arabia, Spain and the UK. Findings delivered insights int…

16 days ago

Read Full Article